Clinical research firm Panthera Biopartners will open the UK’s first trial site in Preston.
Panthera Biopartners was founded by Dr Ian Smith, who previously founded Synexus, a Chorley-based clinical trial firm.
Dr Smith’s Panthera Biopartners are currently undergoing a round of investment which should enable them to open more sites across the Uk and overseas.
Dr Ian Smith, Founder and Medical Director of Panthera told Biospace.com, “It has been so encouraging talking to CROs and major pharma companies.
“They have really welcomed the entry of Panthera Biopartners as an independent SMO (Site Management Organisation) which incorporates new technology into the running of clinical trials and the recruitment of patients.
“We plan to have a number of sites up and running by the first quarter of 2020 with an ongoing expansion program across the UK and overseas.”
Panthera will be shortly announcing a CEO and other senior appointments.